EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY 4.0

Integration of palliative care into phase I oncology trials: A qualitative interview study with patients, informal caregivers, and healthcare providers

Frederick Daenen iD, Anne van Driessche, Anne-Lore Scherrens, Annelies Janssens, Sylvie Rottey, Lore Decoster, Peter A J Stevens, Koen Pardon, Aline De Vleminck, Kim Beernaert

PLOS One · 05.05.2026 · 21 (5) · e0347349

DOI: 10.1371/journal.pone.0347349 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift PLOS One, online erschienen am 05.05.2026. Verfasst von Frederick Daenen und 9 weiteren Autor:innen. Beteiligte Einrichtung: End-of-life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium. Hauptthemen laut MEDLINE: Palliative Care, Caregivers, Neoplasms, Health Personnel. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kom op tegen Kanker.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with advanced cancer participating in phase I clinical trials often face limited survival while experiencing significant symptom burden. Despite evidence supporting early palliative care integration alongside active cancer treatment to improve quality of life, the role of palliative care in phase I trials remains unclear.

Objective

To explore perspectives of patients, informal caregivers, and healthcare providers on quality of life and palliative care in phase I oncology trials, including perceived benefits, barriers, and integration strategies.

Methods

We conducted a multi-perspective qualitative interview study across three Belgian university hospitals from September 2022 to July 2024, using convenience and snowball sampling. The semi-structured interviews were analyzed using qualitative content analysis. Ethical approval was gained from the relevant institutions.

Results

Participants included sixteen patients, five informal caregivers, twelve phase I staff, six oncologists, five palliative care specialists, and four general practitioners. Patients generally reported positive experiences with trial participation, often viewing it as a final opportunity that provided hope and structure. However, quality of life support was inconsistently addressed and largely reactive. While patients reported feeling supported, non-trial providers and caregivers noted limited person-centered care. No systematic approach for introducing palliative care was in place. Palliative care was rarely discussed, hindered by misconceptions such as equating palliative care with terminal care, reluctance from patients and clinicians, and lack of communication between providers. Participants suggested the introduction of routine yet flexible palliative care conversations, as well as improved communication between providers, as strategies towards integration.

Conclusion

Despite recognized care needs, palliative care is not systematically integrated in phase I oncological trials. Quality of life remains a secondary concern. Integrating palliative care in a structured yet flexible manner could support more holistic, patient-centered care. These findings underscore the need to normalize palliative care as a complementary component of phase I oncological trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Palliative CareCaregiversNeoplasmsHealth PersonnelClinical Trials, Phase I as TopicHumansFemaleQuality of LifeMaleMiddle AgedAgedAdultQualitative ResearchBelgium

Autor:innen und Institutionen

  • End-of-life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium.
  • Department of Family Medicine and Chronic Care, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • Department of Public Health and Primary Care, Ghent University, Gent, Belgium.
  • Department of Pulmonology and Thoracic Oncology, Antwerp University Hospital, Antwerp, Belgium.
  • Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium.
  • Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.

ORCID-Profile: Frederick Daenen

Förderung

  • Kom op tegen Kanker

Zitieren

APA

Daenen, F., van Driessche, A., Scherrens, A. L., Janssens, A., Rottey, S., Decoster, L., Stevens, P. A. J., Pardon, K., De Vleminck, A., & Beernaert, K. (2026). Integration of palliative care into phase I oncology trials: A qualitative interview study with patients, informal caregivers, and healthcare providers. PLOS One, 21(5), e0347349. https://doi.org/10.1371/journal.pone.0347349

Vancouver

Daenen F, van Driessche A, Scherrens AL, Janssens A, Rottey S, Decoster L, et al. Integration of palliative care into phase I oncology trials: A qualitative interview study with patients, informal caregivers, and healthcare providers. PLOS One. 2026;21(5):e0347349. doi:10.1371/journal.pone.0347349

BibTeX
@article{Daenen2026,
  author = {Daenen, Frederick and van Driessche, Anne and Scherrens, Anne-Lore and Janssens, Annelies and Rottey, Sylvie and Decoster, Lore and Stevens, Peter A J and Pardon, Koen and De Vleminck, Aline and Beernaert, Kim},
  title = {Integration of palliative care into phase I oncology trials: A qualitative interview study with patients, informal caregivers, and healthcare providers},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {5},
  pages = {e0347349},
  doi = {10.1371/journal.pone.0347349}
}
Kostenlos starten →